<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Despite inactivating APC mutations, <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> express the WNT-effector protein β-catenin in a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> pattern, with strong nuclear expression confined to a fraction of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, often only at the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>'s leading edge </plain></SENT>
<SENT sid="1" pm="."><plain>WNT-reporter constructs allow separation of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with highest WNT/β-Catenin activity, which also express high levels of several putative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell antigens </plain></SENT>
<SENT sid="2" pm="."><plain>Unexpectedly however, these cells do not show exclusive tumorigenicity in xenograft experiments, thus questioning their general stemness phenotype </plain></SENT>
<SENT sid="3" pm="."><plain>Instead, there appears to be significant plasticity between both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with high and low WNT/β-Catenin activity because both cell types can form <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> which again show mixed populations </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, WNT/β-Catenin activity in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells can be modulated by MAPK signaling thus revealing a means of how other signaling pathways contribute to WNT signaling plasticity in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>